ALSAF — Safe SA Cashflow Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for Safe SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | R2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -8.31 | -6.71 | -6.96 | -205 | -1,929 |
| Depreciation | |||||
| Non-Cash Items | 0.808 | 1.07 | 0.353 | 198 | 1,927 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.944 | -1.49 | 0.184 | 68 | -1.22 |
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -5.99 | -6.26 | -5.47 | 64.7 | -3.27 |
| Capital Expenditures | -0.548 | -1.96 | -0.858 | -0.056 | -0.093 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -2.45 | -1 | 0.261 | — | 0.06 |
| Acquisition of Business | |||||
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -2.99 | -2.96 | -0.597 | -0.056 | -0.033 |
| Financing Cash Flow Items | 10.5 | 7.26 | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 11.3 | 7.68 | 5.72 | 1.68 | 3.68 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 2.32 | -1.53 | -0.35 | 66.4 | 0.38 |